Nicolas Moitessier
Professor
- medicinal chemistry
- RNA-targeting molecules
- software
- machine learning
- organic synthesis
Nicolas Moitessier received his Ph.D (1998) from Université Henri Poincaré-Nancy I (France) before moving to Montreal for post-doctoral studies at University of Montreal in medicinal chemistry, and asymmetric synthesis. In 2001, he moved back to Nancy to start an academic career (Chargé de Recherche, CNRS) then back to Montréal in 2003 to join the Â鶹AV Chemistry department. Moitessier’s research interest in drug discovery includes computational methods development and medicinal chemistry focusing on the development of small molecules targeting RNA and inhibitors of an enzyme involved in Parkinson’s disease. In 2010, Moitessier co-founded Molecular Forecaster, a Â鶹AV spin-off company distributing the software developed in his lab and providing research support to the pharmaceutical industry. Since 2016, he has been an Associate editor of the European Journal of Medicinal Chemistry. Over the years, he received several awards, including the Fessenden Professorship and the 2023 CIC Biological and Medicinal Chemistry Lectureship Award.